Celldex Therapeutics (CLDX) Revenue Growth (1y) (2011 - 2026)
Celldex Therapeutics (CLDX) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.45% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 16.73% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 64.03% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 29.63% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -100.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 16.50% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 66.86% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 296.11% |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | -96.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -96.99% |
| Mar 31, 2026 | -97.84% |
| Dec 31, 2025 | -89.70% |
| Jun 30, 2025 | -70.78% |
| Mar 31, 2025 | 345.51% |
| Dec 31, 2024 | -71.56% |
| Sep 30, 2024 | 110.35% |
| Jun 30, 2024 | 832.09% |
| Mar 31, 2024 | -83.87% |
| Dec 31, 2023 | 156.11% |
| Sep 30, 2023 | 272.73% |
| Jun 30, 2023 | 64.42% |
| Mar 31, 2023 | 455.75% |
| Dec 31, 2022 | 382.93% |
| Sep 30, 2022 | 166.01% |
| Jun 30, 2022 | -95.32% |
| Mar 31, 2022 | -74.60% |
| Dec 31, 2021 | -91.18% |
| Sep 30, 2021 | -77.10% |
| Jun 30, 2021 | 1,374.58% |